Stay updated on Viaskin Peanut in Young Children Clinical Trial
Sign up to get notified when there's something new on the Viaskin Peanut in Young Children Clinical Trial page.

Latest updates to the Viaskin Peanut in Young Children Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record for the Viaskin Peanut trial in peanut-allergic children ages 1–3 is displayed, with details on its completed Phase 3 design, eligibility criteria, outcome measures, locations, and supporting documents.SummaryDifference74%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision marker changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange Detected403 Forbidden error now appears on the study page, replacing the study content. The page shows a standard header/footer with a minimal message indicating access is blocked.SummaryDifference18%

Stay in the know with updates to Viaskin Peanut in Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viaskin Peanut in Young Children Clinical Trial page.